Skip to main content

Blood Coagulation Disorders

2
Pipeline Programs
6
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
2 programs
1
Recombinant Factor VIIIPhase 31 trial
Recombinant Factor VIIIN/A1 trial
Active Trials
NCT00969319Completed105Est. Feb 2014
NCT01029340Completed74Est. Mar 2013
CSL Seqirus
CSL SeqirusUK - Maidenhead
1 program
1
Beriplex® P/NPhase 3
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Study of Megakaryocytes From Patients With Abnormal Platelet VesiclesN/A1 trial
Active Trials
NCT00086476Completed3Est. Jun 2011
Genome & Company
Genome & CompanyKorea - Suwon
1 program
Study of Megakaryocytes From Patients With Abnormal Platelet VesiclesN/A
Universal Biosensors
Universal BiosensorsAustralia - Rowville
1 program
Study to Test the Accuracy of a Prototype Handheld PT/INR DeviceN/A1 trial
Active Trials
NCT01349712Unknown200Est. Nov 2011
CSL Behring
CSL BehringIL - Bradley
1 program
Beriplex® P/NPHASE_31 trial
Active Trials
NCT00708435Completed216Est. Nov 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BayerRecombinant Factor VIII
CSL BehringBeriplex® P/N
Universal BiosensorsStudy to Test the Accuracy of a Prototype Handheld PT/INR Device
BayerRecombinant Factor VIII
Human BioSciencesStudy of Megakaryocytes From Patients With Abnormal Platelet Vesicles

Clinical Trials (5)

Total enrollment: 598 patients across 5 trials

NCT01029340BayerRecombinant Factor VIII

Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A

Start: Dec 2009Est. completion: Mar 201374 patients
Phase 3Completed
NCT00708435CSL BehringBeriplex® P/N

Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy

Start: Jun 2008Est. completion: Nov 2010216 patients
Phase 3Completed
NCT01349712Universal BiosensorsStudy to Test the Accuracy of a Prototype Handheld PT/INR Device

Study to Test the Accuracy of a Prototype Handheld PT/INR Device

Start: May 2011Est. completion: Nov 2011200 patients
N/AUnknown
NCT00969319BayerRecombinant Factor VIII

Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America

Start: Sep 2009Est. completion: Feb 2014105 patients
N/ACompleted
NCT00086476Human BioSciencesStudy of Megakaryocytes From Patients With Abnormal Platelet Vesicles

Study of Megakaryocytes From Patients With Abnormal Platelet Vesicles

Start: Jun 2004Est. completion: Jun 20113 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.